comparemela.com

Latest Breaking News On - Ruth gimeno - Page 1 : comparemela.com

Amgen taking different path to weight loss windfall

The popularity of a new generation of weight-loss medicines is inspiring a growing number of drugmakers to pursue paths emulating Eli Lilly's highly-effective Zepbound, but Amgen is taking a unique approach. Zepbound, which promotes the most weight loss among treatment options currently on the market, stimulates two different gut hormones to fight obesity, GLP-1 and GIP. Amgen's most advanced experimental candidate activates GLP-1 while blocking GIP.

Lilly signs another AI deal, this one for obesity – Inside INdiana Business

Lilly signs another AI deal, this one for obesity – Inside INdiana Business
insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.

Lilly signs another AI deal, this one for obesity – Indianapolis Business Journal

Fauna Bio, based in the San Francisco area, said Thursday it will give Lilly access to its AI platform, called Convergence, to support preclinical drug discovery efforts in obesity.

Lilly pushes deeper into obesity with Fauna Bio deal

The $494 million deal gives Lilly access to Fauna’s Convergence AI platform, which analyzes data from hibernating animals to identify drug targets.

Fauna Bio Announces Strategic Collaboration with Lilly to Discover Novel Obesity Targets Using Convergencetm AI Platform

Fauna Bio Announces Strategic Collaboration with Lilly to Discover Novel Obesity Targets Using Convergencetm AI Platform
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.